BLRX.TA

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$2M	+13.1%	$-0.00	$-0.00–$-0.00	—	1
2027	$2M	+37.1%	$-0.00	$-0.00–$-0.00	—	1
2028	$8M	+253.1%	$-0.00	$-0.00–$-0.00	—	1
2029	$8M	-5.7%	$-0.00	$-0.00–$-0.00	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 4 of the last 8 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-08-31	$-0.00	$-0.00	-386.5%
2026-05-27	$-0.01	$-0.00	+42.6%
2026-03-23	$-0.00	$-0.00	+30.2%
2025-11-24	$-0.00	$-0.00	+64.9%
2025-08-14	$-0.00	$-0.01	-185.9%
2025-05-27	$-0.01	$0.01	+283.9%
2025-03-31	$-0.00	$-0.01	-98.4%
2024-11-25	$-0.01

DCF fair valuemodel estimate

Intrinsic value

$0.06

Price

$1.30

Implied downside

-96%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
BLRX.TABioLineRx Ltd.	$1.30	+0.00%	$34M	—
BOLT.TABioLight Life Sciences Ltd.	$292.70	-1.08%	$26M	—
CANF.TACan-Fite BioPharma Ltd.	$345.30	-1.03%	$15M	—
CBI.TAClal Biotechnology Industries Ltd.	$24.90	+0.81%	$39M	—
ENLV.TAEnlivex Therapeutics Ltd.	$269.70

BioLineRx Ltd.

BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.

www.biolinerx.com

Employees: 22
IPO / List date: Feb 6, 2007
HQ: IL

Held by traders on TradeandTell

No one on the platform currently holds BLRX.TA.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in BLRX.TA as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded BLRX.TA yet.